y olog nology
sustaina s ble f em
tech eadutomated automwaatre ems
st ainable
s problem
ons specificati
A
developin
publicly
enel rgy
ions specificat
A
s problem
gies technolo
syst
soft
c i t e h t n y s public public
s organism
developing
ly dica publicm e
energy
c i t e h synt assemb
e innovativ
ly
software
ly assemb lly comercia
medical
uels
es approacctuhring
c therapeuti
wealth
h c a o r p p y a g o proce cts biold r producepte manufactu accepted
scientific
l industria sses
manufa
safe
based
ac roadmap c ly al scientifi comerci societal Europe living use synthetic
workf
echemicals h t r o f s catiroodnuction
lly economica
orm fullyplatf needs
support
in g
scale
proven
p
c
vibrant
escnienttific m p o l e v e d
sized
sta
P THETIC UK SYN ATION GROU IN D R O O C
l biologica s n solutio orkforce w
one
driGvd YeR andeOrAdDMAenP able wi BIOLOn
enable
synthetic areas
DNA
tools
s erapeutic oth bisaf eguards
pat
mmunity cohw ays
includ
resourced
UKbase
anies comp ing
benefit
accurate
world
range
ng underpinni
delivering plastihcsemical
type-in
cant fits signifi
appli
route
integrated
s regulation lagging
le responsib
organisms
OpenPlant
strong
p a m road
solving
markets e experienc
atorolseas
integrated
g managin
derived
base enable gical biolo ns solutioor ce
producing
ing underpinn
markets standard
resourced
mm ion progra lab/product
bene organisms
poke large bes
export
le responsib
perience solving ex
science
chemplaicstiacsls
proven
ns applicatio
l supportnge safe a i r t s u d in leading ocesserasdevelopment pr sector one
omticically erap thec oneu
g o l o i s b t c produ based
University of Cambridge, John Innes Institute, Earlham Institute Directors: Prof. Jim Haselo, Prof. Anne Osbourn Principal Investigators: Prof. Sir David Baulcombe, Prof. Dale Sanders website: https://www.openplant.org
Number of utility and plant patents granted per year
transgenic plants 1983
The evolving landscape of plant varietal rights in the United States, 1930–2008, P. Pardey et al., Nature Biotechnology 31, 25–29 (2013).
Consolidation of ownership in plant biotechnology
Synthetic Biology: reprogramming genetic systems
Federici, Rudge, Pollak, Haseloff, Gutierrez, 2013
OpenPlant Electronics
Biology
VLSI chips, hardware
commercial bioproducts
Linux, open hardware
model
 systems
connectors, protocols
DNA parts, assembly
academia
academia
Open standards and technologies for engineering plants
t a i o v n o i t o n a vn
P arts
Outreach & Exchange
on
NA
O
pe
ti
D
its
Inn o In
n t a l Tra P
n Auto m
a
Research & Development
Global Challenges Research Fund (GCRF)
New UK Aid Strategy • In 2013, the UK formally committed to spending 0.7% GNI per annum on Official Development Assistance (ODA) • In November 2015, new UK aid strategy published: ‘…..the UK’s development spending will meet our moral obligation to the world’s poorest and also support our national interest……’
£1.5Bn Global Challenges Research Fund The GCRF will: – promote the economic development and welfare of developing countries. – deploy world class research capability within the UK to address the challenges facing developing countries. – harness UK research expertise to strengthen resilience and response to crisis. – be delivered primarily through the Research Councils and the National Academies. – project selection will be managed through independent review in accordance with the Haldane principle.
GCRF allocation to RCUK
OECD DAC Country List
What is Official Development Assistance (ODA)compliant research? • Research that is directly and primarily relevant to the problems of developing countries. • Research should investigate a specific problem or seek a specific outcome which will impact on developing countries in the immediate or longer-term. • Research proposals can focus on a development topic or address an un-met capacity need in the partner country. • Research does not need to be solely relevant to developing countries, but developing countries should be the primary beneficiaries.
GCRF – Global Challenge “themes”
Aims for Africa-UK Practical Synthetic Biology programme To share knowledge of new technologies: i) Standardisation of DNA parts and genome editing ii) Transient expression and natural product discovery iii) Cell-free gene expression. • To identify key problems that might be addressed by application of these technologies. • Exploit new opportunities for education, training and “maker” culture • To identify synergies between UK and African groups and the potential for connections between southern, west and east Africa hubs. • To estimate technical challenges, and the scale of investments required.